Alexandra Stainton
Overview
Explore the profile of Alexandra Stainton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zbukvic I, Fisher E, Stainton A, Bryce S, Kartal D, Kunin M, et al.
Early Interv Psychiatry
. 2025 Jan;
19(2):e70004.
PMID: 39865466
Aim: Accurate and appropriate cognitive screening can significantly enhance early psychosis care, yet no screening tools have been validated for the early psychosis population and little is known about current...
2.
Bienek O, Allott K, Antonucci L, Bertolino A, Bonivento C, Borgwardt S, et al.
Eur Child Adolesc Psychiatry
. 2024 Nov;
PMID: 39503777
The aim of this study was to examine the neurocognitive deficits associated with the first episode of major depressive disorder (recent onset depression, ROD) in adolescents as compared to adult...
3.
Bryce S, Cheng N, Stainton A, Zbukvic I, Dalton A, Ojinnaka A, et al.
Early Interv Psychiatry
. 2024 Oct;
19(1):e13615.
PMID: 39358808
Aim: To explore the cognitive treatment preferences of young people with mental illness. Methods: Two-hundred and fourteen people, aged 12-25 years, were surveyed about their treatment priorities. Participants were specifically...
4.
Allott K, Pert A, Rattray A, Cooper R, Winther Davy J, Grunwald L, et al.
Psychiatr Rehabil J
. 2024 Jul;
47(4):291-302.
PMID: 39052404
Objective: To examine the evidence and practice of antipsychotic dose reduction from the lens of biomedical ethics (specifically principlism) to support evidence-based practice and patient choice and self-determination. Methods: An...
5.
Gates J, Ellinghaus C, Valentine L, Kamitsis I, Stainton A, Harrigan S, et al.
Psychiatr Rehabil J
. 2024 Jul;
47(4):313-321.
PMID: 39023955
Objective: The current guidelines recommend continuation of antipsychotic medication for a minimum of at least 1 year following a first episode of psychosis (FEP). There have been several trials investigating...
6.
Stainton A, Bryce S, Rattray A, Pert A, Zbukvic I, Fisher E, et al.
Early Interv Psychiatry
. 2024 May;
19(1):e13558.
PMID: 38794960
Aim: Cognitive impairments are a core feature of first-episode psychosis (FEP) and one of the strongest predictors of long-term psychosocial functioning. Cognition should be assessed and treated as part of...
7.
Bonivento C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, Lencer R, Meisenzahl E, et al.
Br J Psychiatry
. 2024 Mar;
224(5):185.
PMID: 38497099
No abstract available.
8.
Stainton A, Cheng N, Bryce S, Dalton A, Ojinnaka A, Zbukvic I, et al.
Schizophr Res
. 2023 Nov;
262:30-31.
PMID: 37922840
No abstract available.
9.
Bonivento C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, Lencer R, Meisenzahl E, et al.
Br J Psychiatry
. 2023 Oct;
223(4):485-492.
PMID: 37846967
Background: Neurocognitive deficits are a core feature of psychosis and depression. Despite commonalities in cognitive alterations, it remains unclear if and how the cognitive deficits in patients at clinical high...
10.
Wenzel J, Badde L, Haas S, Bonivento C, Van Rheenen T, Antonucci L, et al.
Neuropsychopharmacology
. 2023 Sep;
49(3):573-583.
PMID: 37737273
Cognitively impaired and spared patient subgroups were identified in psychosis and depression, and in clinical high-risk for psychosis (CHR). Studies suggest differences in underlying brain structural and functional characteristics. It...